ADHD Innovation
Discover our advanced technology to
fit your patients' unique needs.
![Mobile Hero](/images/tris-pharma-adhd-hcp-hero-bg-mobile.png)
Tris Pharma offers amphetamine and methylphenidate treatment options for patients 6 years and older with ADHD.
Amphetamine Treatments
Methylphenidate Treatments
Methylphenidate Treatments
![Tris ADHD LiquiXR Technology Logo](https://www.trisadhdhcp.com/images/liquixr-technology-logo-1c9fd6cdfd143260bc0b5127f2cfe64c.png)
![LiquiXR Technology Tablet & Liquid Demonstration Graphic](https://www.trisadhdhcp.com/images/tris-pharma-adhd-liquixr-technology.png)
Our innovative technology provides consistent drug delivery with predictable symptom control.
![LiquiXR Technology Tablet & Liquid Demonstration Graphic](https://www.trisadhdhcp.com/images/tris-pharma-adhd-liquixr-technology.png)
![Tris ADHD LiquiXR Technology Logo](https://www.trisadhdhcp.com/images/liquixr-technology-logo-1c9fd6cdfd143260bc0b5127f2cfe64c.png)
Our innovative technology provides consistent drug delivery with predictable symptom control.
Request more information
Click below to sign up to receive more information about Tris Pharma and the Tris family of products.
You can also request a visit from a Tris Pharma representative.
ADHD, Attention Deficit Hyperactivity Disorder; ER, extended-release; IR, immediate-release.
References: 1. Kando JC, King TR, Pardo A. A novel, modified-release drug delivery technology containing amphetamine and methylphenidate ion-exchange complexes. Poster presented at: American Psychiatric Association Annual Meeting; May 1-3, 2021.